Renal Therapies Group

The Renal Therapies Group (RTG), a division of Fresenius Medical Care North America (FMCNA), is passionately committed to helping people with end-stage renal disease (ESRD) lead more active and fulfilling lives. Through its two divisions (Renal Technologies and Renal Pharmaceuticals), RTG delivers hemodialysis and peritoneal dialysis equipment, as well as renal pharmaceuticals in support of the clinical and home environments.

Contact Us
The Renal Therapies Group (RTG), a division of Fresenius Medical Care North America (FMCNA)

Empowering Care


Every Day. Every Way. Everywhere.

Fresenius Renal Technologies

As the market leader, we combine clinical expertise with research and development to provide cost-efficient dialysis equipment and products that improve care.

Key Offerings include:

Fresenius renal technologies

Fresenius Renal Pharmaceuticals

The partner of choice for biotech and pharmaceutical companies seeking to provide pharmaceutical treatment to ESRD patients.

Key Offerings include:

Fresenius renal pharmaceuticals